This program is not certified for continuing education credit. The content and opinions expressed are those of the sponsor and/or presenter(s) and are not necessarily those of the AAAAI.
Friday, February 24, 2023
8:15 PM – 8:30 PM CST Registration & Dinner
8:30 PM – 9:30 PM CST Symposium
Grand Hyatt San Antonio River Walk
600 E. Market Street
San Antonio, TX 78205
Meeting Room: Texas C Ballroom, Fourth Floor
- Interactive case-based learning
- Simulation Challenge and Whiteboard animations
- Create your own personalized poster
Cecelia Damask, DO
Lake Mary ENT and Allergy
Lake Mary, FL
Stella E. Lee, MD
Section Chief, Rhinology
Division of Otolaryngology—Head and Neck Surgery
Department of Surgery
Brigham and Women’s Hospital
Harvard Medical School
After completing the CME activity, learners should be better able to:
- Describe the etiopathogenesis of CRSwNP as a foundation for informed treatment decision-making.
- Discuss data from clinical trials assessing the efficacy, safety, and tolerability of available and emerging therapeutic options for patients with CRSwNP.
- Identify patients who may benefit from biologic therapies for treatment of CRSwNP.
This activity is designed to meet the educational needs of allergists, immunologists, otolaryngologists, primary care physicians, nurses, nurse practitioners, pharmacists, and other members of the multidisciplinary team to ensure an up-to-date understanding of the latest data in management of CRSwNP.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at [email protected]